Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapropterin for radiation-induced dermatitis in HNSCC
NCT05299203Phase 1Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
01
Overview
Phase 1, open-label, single-arm trial of sapropterin in radiation-induced dermatitis (RID), sponsored by West China Hospital of Sichuan University. Primary endpoint: Radiation dermatitis grading change. Status: unknown.
02
Drugs
sapropterin
03
Conditions
radiation-induced dermatitis (RID)
Beyond the preview
Go deeper on NCT05299203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05299203.